AtriCure Earns CE Mark for AtriClip PRO2

AtriCure has received CE mark approval for its AtriClip PRO2 left atrial appendage exclusion system, the company announced Wednesday.

The device is designed to provide increased functionality to block the left atrial appendage during minimally-invasive surgical procedures.

The device was launched in April 2016 in the U.S. — Anisa Jibrell